Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kalima Muhetaer
Institution:
First Affiliated Hospital of Xinjiang Medical University
Observed institution:
First Affiliated Hospital of Xinjiang Medical University
ORCID:
0009-0007-9703-1688
Observed ORCID:
0009-0007-9703-1688
OpenAlex ID:
A5119329166
Efficacy and safety of PD-1 inhibitors in combination with chemotherapy as first-line treatment for HER2-negative advanced gastric or gastroesophageal junction cancer across subgroups: A comprehensive systematic review and meta-analysis
2025
·
Muhetaibaier Hairoula
, Yu Wei
, et al.
·
Medicine
·
2
Immunotherapy combined with chemotherapy as first-line treatment for HER2-negative advanced gastric or gastroesophageal junction cancer: systematic review and Bayesian network meta-analysis based on specific PD-L1 expression levels
2026
·
Wen Yi
, Kalima Muhetaer
, et al.
·
BMC Cancer
·
1
The Role of COQ10B in Tumor Progression and Its Association with Immune Escape in Esophageal Squamous Cell Carcinoma: A Multi-Omics and Functional Analysis
2026
·
Leiyu Cao
, Xingfang Wei
, et al.
·
International Journal of General Medicine
The novel integrin-linked kinase inhibitor nilotinib suppresses cancer progression by promoting ubiquitylation of autoimmune regulator in oesophageal squamous cell carcinoma
2026
·
Xiaoli Ma
, Yu Wei
, et al.
·
Anti-Cancer Drugs
Show more works
View as search
Works count:
4
Citation count:
3
H-index:
1
I10-index:
Year
Topic
Type